Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients
Clinical trial NCT04830449 · COMPLETED
Trial details
- NCT number
- NCT04830449
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-29
- Primary completion
- 2021-08-24
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.